A new method of lyophilisation or freeze drying that uses a single, sterilisable, closed vessel to deliver lump free, fine powder product has the capability to revolutionise the production of bulk pharmaceutical powders.
With the benefits of improved operator safety, reduced equipment requirements and high quality, contaminant-free end product results, the proven, active freeze drying technology, from Hosokawa Micron is making pharmaceutical manufacturers worldwide reconsider their existing tray-type freeze drying methods.
Hosokawa Micron’s active freeze drying technology incorporates the use of a jacketed and stirred dryer and collection filter (Figure 1). Material is quickly frozen inside the vessel.
Not yet a Subscriber?
This is a small extract of the full article which is available ONLY to premium content subscribers. Click below to get premium content on Manufacturing Chemist.
Subscribe now Already a subscriber? Sign in here.